What other signal did our AI researcher identify regarding "perrigo reports first quarter 2026 financial results from continuing operatio..."? (2)

Core net sales $842M, down 8.3% YoY

What other signal did our AI researcher identify regarding "perrigo reports first quarter 2026 financial results from continuing operatio..."? (3)

Diluted EPS $(2.81) due to $330.8M goodwill impairment

What other signal did our AI researcher identify regarding "perrigo reports first quarter 2026 financial results from continuing operatio..."? (4)

Divested Dermacosmetics business for ~€306M

What other signal did our AI researcher identify regarding "perrigo reports first quarter 2026 financial results from continuing operatio..."? (5)

Specialty Care segment grew driven by Compeed, Opill, ellaOne

prnewswire.com

www.prnewswire.com · May 6, 2026

Negative

perrigo reports first quarter 2026 financial results from continuing operations 302763932

LEADERTAX_FNCACT_PRESIDENTUSPEC_POLITICS_GENERAL1TAX_FNCACT_VICE_PRESIDENT

All News Read the full story on prnewswire.com

The full article is on the original publisher site. This page only shows the headline and a very short excerpt.

AI insight

AI-generated

Perrigo's Q1 results show revenue decline and impairment charge, but divestiture strengthens balance sheet. Impact is company-specific, not sector-wide. Weak commercial mechanism for broader sectors; only company-level margin and revenue effects.

Signals our AI researcher identified

Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.

Net sales $969M, down 7.2% YoY
Core net sales $842M, down 8.3% YoY
Diluted EPS $(2.81) due to $330.8M goodwill impairment
Divested Dermacosmetics business for ~€306M
Specialty Care segment grew driven by Compeed, Opill, ellaOne